American journal of clinical dermatologyApr 9, 2026

How GLP-1 Receptor Agonists May Affect Hair: Helpful or Harmful?

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated Apr 10, 2026

Abstract

Some studies suggest hair regrowth in patients using glucagon-like peptide-1 receptor agonists (GLP-1RAs) for type II diabetes and obesity.

Evidence linking GLP-1RAs to hair-related conditions is inconsistent.
Certain studies report hair regrowth in patients with androgenetic alopecia.
Decreased inflammatory cells have been noted in patients with cicatricial alopecia using GLP-1RAs.
Conversely, many reports associate GLP-1RAs with telogen effluvium, a form of hair loss.
Careful clinical evaluation and monitoring of patients on GLP-1RAs is advised.
Further controlled studies are needed to clarify the impact of GLP-1RAs on hair biology.

Simplified

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the treatment of type II diabetes and obesity. Since their introduction, studies continue to reveal their beneficial effects in a range of other conditions. However, hair loss associated with GLP-1RAs is still a controversial topic. This narrative review explores the current evidence linking GLP-1RAs to hair-related conditions because, while some studies have reported hair regrowth in patients with androgenetic alopecia and a decrease in inflammatory infiltrate in patients with cicatricial alopecia, many more have suggested association with telogen effluvium. Given the heterogeneity of current reports, careful clinical evaluation, monitoring weight trends, and assessing relevant laboratory parameters is recommended. Prospective, controlled studies, including immunohistochemical or molecular profiling of GLP-1 receptor expression in human hair follicles, are necessary to better clarify the potential role of GLP-1RAs in hair biology, to inform safe prescribing practices and to avoid discontinuation of a beneficial treatment.

Full Text

Full text is available at the source.

View Full Text ↗

Funding

Competing interests

Declarations. Conflicts of Interest: None. Ethical Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Availability of Data and Material: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Code Availability: Not applicable. Authors Contributions: Conceptualization—M.I., S.M.S.J.; investigation—all authors; project administration/supervision—M.I., S.R.L.; writing—original draft—M.I., G.C., S.M.S.J.; writing—review and editing—all authors. All authors read and approved the final manuscript.

PubMed

How GLP-1 Receptor Agonists May Affect Hair: Helpful or Harmful?

Abstract

Full Text

Funding

Competing interests

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief

Abstract

Full Text

Funding

Competing interests

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the glp-1 therapies brief